DIVIGEL Drug Patent Profile
✉ Email this page to a colleague
When do Divigel patents expire, and what generic alternatives are available?
Divigel is a drug marketed by Vertical Pharms and is included in one NDA.
The generic ingredient in DIVIGEL is estradiol. There are seventy-five drug master file entries for this compound. Forty-nine suppliers are listed for this compound. Additional details are available on the estradiol profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Divigel
A generic version of DIVIGEL was approved as estradiol by BARR LABS INC on October 22nd, 1997.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for DIVIGEL?
- What are the global sales for DIVIGEL?
- What is Average Wholesale Price for DIVIGEL?
Summary for DIVIGEL
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 109 |
| Clinical Trials: | 4 |
| Patent Applications: | 4,061 |
| Drug Prices: | Drug price information for DIVIGEL |
| What excipients (inactive ingredients) are in DIVIGEL? | DIVIGEL excipients list |
| DailyMed Link: | DIVIGEL at DailyMed |
Recent Clinical Trials for DIVIGEL
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Scientific Research Institute of Public Health, Russian Federation | Phase 4 |
| University Hospital, Bonn | Phase 1 |
| Päivikki and Sakari Sohlberg Foundation, Finland | N/A |
Pharmacology for DIVIGEL
| Drug Class | Estrogen |
| Mechanism of Action | Estrogen Receptor Agonists |
US Patents and Regulatory Information for DIVIGEL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Vertical Pharms | DIVIGEL | estradiol | GEL;TRANSDERMAL | 022038-001 | Jun 4, 2007 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Vertical Pharms | DIVIGEL | estradiol | GEL;TRANSDERMAL | 022038-004 | Aug 17, 2018 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Vertical Pharms | DIVIGEL | estradiol | GEL;TRANSDERMAL | 022038-002 | Jun 4, 2007 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Vertical Pharms | DIVIGEL | estradiol | GEL;TRANSDERMAL | 022038-003 | Jun 4, 2007 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
